9-bromo-1-nonanol acetate

We are 9-bromo-1-nonanol acetate CAS:53596-82-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:9-bromo-1-nonanol acetate
CAS.NO:53596-82-0
Synonyms:9-bromo-1-nonanol acetate
acetic acid,9-bromononan-1-ol
9-bromononyl acetate
acetic acid-(9-bromo-nonyl ester)
1-acetoxy-9-bromo-nonane
9-bromo,1-nonanol acetate
1-Nonanol,9-bromo-,acetate
Molecular Formula:C11H21BrO2
Molecular Weight:265.18724
 
Specification:
Appearance:Colorless liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

9-bromo-1-nonanol acetate


Related News: European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market.ethyl 3-chlorosulfonyl-1-methylpyrazole-4-carboxylate CAS:93621-38-6 European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market.3-Bromobenzotrifluoride As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. (6S) – 5- Azaspiro [2.4] heptano- 5, ​​6- ácido dicarboxílico 5- (1, 1- dimetiletil) éster sal de potasio CAS:1441673-92-2 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
N-(3-chloro-4-fluorophenyl)-7-(3-morpholin-4-ylpropoxy)-6-nitroquinazolin-4-amine View Details
2-Amino-4-chloro-6-methoxypyrimidine View Details
2-Methylacetoacetanilide View Details
dGMP manufacturer 4-chloro-7-methoxyquinoline-6-carboxamide manufacturer 2-Chloro-3-picoline manufacturer 2-Bromoisobutyrylchloride manufacturer Di(pyrrolidin-1-yl)methanone manufacturer